BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Titan Medical Reports 2017 Financial Results

  TITAN Medical announces financial results for the 12 months ended December 31, 2017.

  February 14, 2018

   · 

  7 min read
• Business

  Carmat: 2017 Annual Results

  CARMAT today announces its annual results for the year ending December 31, 2017.

  February 14, 2018

   · 

  7 min read
• BioMidwest

  Life Spine Announces the Launch of www.micro-invasive.com with Key Focus on Healthcare Economics and Clinical Outcomes

  The website features a streamlined and simplified design, along with clinical and economical sections that focus on educating patients and medical professionals on the expanding benefits of this technology.

  February 14, 2018

   · 

  1 min read
• 

  FDA

  FDA Green Lights Banyan Biomarkers’ First Blood Test to Help Diagnose Concussions

  Banyan BTI is the first in vitro diagnostic blood test to aid in the evaluation of patients with suspected TBI, also known as concussion.

  February 14, 2018

   · 

  5 min read
• Business

  SanBio and Teijin to Terminate Licensing Agreement regarding SB623 for Stroke Treatment

  SanBio and Teijin Limited jointly announced today that they would terminate the exclusive licensing agreement signed in 2009 regarding the development and marketing of SB623 for stroke treatment in Japan.

  February 14, 2018

   · 

  2 min read
• Biotech Bay

  National Cancer Institute Awards Tosk $2 Million Cancer Drug Development Grant

  Tosk, Inc. announced today that it has received a two-year, $2 million Phase II SIBR grant from the National Cancer Institute (NCI) to support its kRAS oncogene drug research and development program, a high priority for the NCI.

  February 14, 2018

   · 

  1 min read
• Policy

  Neurocrine Biosciences Will File NDA for Opicapone for Parkinson’s Disease Based on Existing Pivotal Clinical Trial Data

  Neurocrine will proceed with plans to file the NDA for opicapone during the first half of 2019.

  February 14, 2018

   · 

  7 min read
• Bio NC

  Veloxis Secures $60M in Debt Financing

  Veloxis today announced that it has obtained $60M of capital from funds managed by Athyrium.

  February 14, 2018

   · 

  3 min read
• 

  Business

  LivaNova Takes Out TandemLife in $250M Deal

  Company will add advanced cardiopulmonary temporary support solutions to its portfolio.

  February 14, 2018

   · 

  6 min read
• Deals

  Exactech Announces Completion of Merger with TPG Capital

  Exactech announce the successful completion of the previously announced merger agreement with TPG Capital, pursuant to which TPG has acquired all of the issued and outstanding common stock of Exactech.

  February 14, 2018

   · 

  4 min read